Staar Surgical (STAA) Cash & Current Investments (2010 - 2026)

Staar Surgical has reported Cash & Current Investments for 17 years, with the latest figure at $163.9 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Current Investments fell 26.43% year-over-year to $163.9 million; the trailing twelve-month figure through Apr 2026 stood at $163.9 million (down 26.43% YoY), and the FY2026 full-year result was $187.5 million, down 18.64% from the prior year.
• Cash & Current Investments for Q2 2026 stood at $163.9 million, down from $187.5 million in the prior quarter.
• The five-year high for Cash & Current Investments was $245.1 million in Q1 2024, with the low at $163.9 million in Q2 2026.
• Historically, Cash & Current Investments has averaged $207.5 million across 5 years, with a median of $203.8 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Current Investments climbed 25.43% — and 2026, when it dropped 26.43%.
• Staar Surgical's Cash & Current Investments stood at $211.6 million in 2022, then advanced by 4.29% to $220.7 million in 2023, then advanced by 4.43% to $230.5 million in 2024, then dropped by 16.41% to $192.7 million in 2025, then slipped by 14.93% to $163.9 million in 2026.
• The last three Cash & Current Investments figures came in at $163.9 million (Q2 2026), $187.5 million (Q1 2026), and $192.7 million (Q3 2025), per Business Quant data.